All News Results

  • Stock Futures Advance on Covid-19 Vaccine Results

    U.S. stock futures rose Monday, putting Wall Street on track to open the week on the front foot after promising results on a Covid-19 vaccine bolstered hopes for an economic rebound in 2021.. Futures tied to the S&P 500 climbed 0.4%, after the benchmark stocks gauge snapped a two-week winning streak on Friday. Nasdaq-100 futures gained 0.3%, while Dow Jones Industrial Average futures advanced 0.5%.

  • Growth Pace of U.S. Economic Activity Ticks Up in October -- Chicago Fed

    The U.S. economy expanded at an above-average rate in October at a quicker pace than that of the previous month, signaling the economy entered the fourth quarter on a stronger footing, data from the Federal Reserve Bank of Chicago showed Monday. The Chicago Fed National Activity Index stood at 0.83 in October, up from an upwardly revised 0.32 in September. The figure is above economists' consensus, who polled by FactSet expected the indicator to be at 0.23.

  • Regeneron, Warner Music, Royal Caribbean: What to Watch When the Stock Market Opens Today

    Here's what we are watching as markets kick into gear Monday. --U. S. stock futures rose Monday, putting Wall Street on track to open the week with gains after promising results on a Covid-19 vaccine trial bolstered hopes for an economic recovery. S&P 500 futures added 0.6%, and Dow Jones Industrial Average futures gained 0.7%.

  • Regeneron, Warner Music, Royal Caribbean: What to Watch When the Stock Market Opens Today

    Here's what we are watching as markets kick into gear Monday. --U. S. stock futures rose Monday, putting Wall Street on track to open the week with gains after promising results on a Covid-19 vaccine trial bolstered hopes for an economic recovery. S&P 500 futures added 0.6%, and Dow Jones Industrial Average futures gained 0.7%.

  • Merck to Buy OncoImmune for $425 Million Amid Race for Covid-19 Treatments -- Update

    Merck& Co. is buying the biopharmaceutical company OncoImmune, which has reported positive results from a late- stage study of a coronavirus therapeutic candidate, for $425 million in cash. The acquisition is the big drugmaker's latest in its catch-up in the most important vaccine and treatment chase in modern history. Earlier Monday, AstraZeneca PLC and the University of Oxford said their Covid-19 vaccine was as much as 90% effective in preventing infections without serious...

  • Regeneron, Warner Music, Royal Caribbean: What to Watch When the Stock Market Opens Today

    Here's what we are watching as markets kick into gear Monday. --U. S. stock futures rose Monday, putting Wall Street on track to open the week with gains after promising results on a Covid-19 vaccine trial bolstered hopes for an economic recovery. S&P 500 futures added 0.5%, and Dow Jones Industrial Average futures gained 0.6%.

  • Danone to Cut Workforce as Part of Restructuring to Meet New Goals -- Update

    --Danone (GPDNF) plans to reduce up to 2,000 positions in its local and global headquarters, and implement a "local-first" strategy. --The food company is targeting savings of EUR1 billion by 2023 and recurring operating margin in the mid-to-high-teen levels in the mid term. --The reorganization of its structure will lead to one-off costs of around EUR1.4 billion between 2021 and 2023.

  • Merck to Buy OncoImmune Amid Covid-19 Vaccine Development

    Merck& Co. is buying the biopharmaceutical company OncoImmune, which has reported positive results from a late- stage study of a coronavirus therapeutic candidate, for $425 million in cash. The acquisition is the big drugmaker's latest in its catch-up in the most important vaccine chase in modern history. Earlier Monday, AstraZeneca PLC and the University of Oxford said their Covid-19 vaccine was as much as 90% effective in preventing infections without serious side effects...

  • Europe's Economy Set to Contract Again as Lockdowns Bite

    The European economy appears set for a fresh contraction in the final quarter of 2020, as business surveys indicate that lockdowns aimed at containing the coronavirus have led to a sharp decline in activity in the dominant services sector. The new lockdowns mostly came into force in the final week of October. Although narrower than those introduced in the spring, the new measures appear to have hit those services that require close physical proximity almost as hard, while...

  • China Vows to Investigate Bond-Market Misconduct

    China warned it would show zero tolerance for misconduct in the debt markets, after a series of defaults by state- backed groups unsettled investors. The warning came from the Financial Stability and Development Committee, a body that groups together China's central bank and other top financial regulators and that is chaired by Vice Premier Liu He, President Xi Jinping's point person on economic and financial issues. It followed a series of interventions by other actors,...

Search News

Filter Results

Publication Date
Topic
Provider

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.